Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Zepbound (tirzepatide) injection, for subcutaneous use: Highlights of prescribing information
No you didn't
[1] [2] As a glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, tirzepatide requires consistent subcutaneous administration to maintain therapeutic efficacy
It is also often explored within approaches that consider cardiovascular health as part of broader metabolic care
For the vast majority of patients with type 2 diabetes, the metabolic advantages clearly outweigh any potential bone-related risks
US$ 24.52
US$ 26.98
US$ 29.58
US$ 26.87
US$ 23.71
US$ 26.86
